Histamine H4 receptor ligands and their potential therapeutic applications: an update

Bibliography

• Kiss R, Keserű GM. Histamine H4 receptor ligands and their potential therapeutic applications. Expert Opin Ther Patents 2009;19:119-35
   PubMed Web of Science ®Google Scholar
• Engelhardt H, Smits RA, Leurs R, A new generation of anti-histamines: histamine H4 receptor antagonists on their way to the clinic. Curr Opin Drug Discov Devel 2009;12:628-43
   PubMedGoogle Scholar
• Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009;157:24-33
   PubMed Web of Science ®Google Scholar
• Lazewska D, Kiec-Kononowicz K. Azines as histamine H4 receptor antagonists. Front Biosci (Schol Ed) 2012;4:967-87
   PubMedGoogle Scholar
• Marson CM. Targeting the histamine H4 receptor. Chem Rev 2011;111:7121-56
   PubMed Web of Science ®Google Scholar
• Gutzmer R, Gschwandtner M, Rossbach K, Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus. Front Biosci (Schol Ed) 2011;3:985-94
   PubMedGoogle Scholar
• Tey HL, Yosipovitch G. Targeted treatment of pruritus: a look into the future. Br J Dermatol 2011;165:5-17
   PubMed Web of Science ®Google Scholar
• Raap U, Stander S, Metz M. Pathophysiology of itch and new treatments. Curr Opin Allergy Clin Immunol 2011;11:420-7
   PubMed Web of Science ®Google Scholar
• Metz M, Stander S. Chronic pruritus – pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2010;24:1249-60
   PubMed Web of Science ®Google Scholar
• Greaves MW. Pathogenesis and treatment of pruritus. Curr Allergy Asthma Rep 2010;10:236-42
   PubMed Web of Science ®Google Scholar
• Yu B, Shao Y, Zhang J, Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis. Br J Dermatol 2010;162:1038-43
   PubMed Web of Science ®Google Scholar
• Thurmond RL, Desai PJ, Dunford PJ, A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 2004;309:404-13
   PubMed Web of Science ®Google Scholar
• Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol 2010;130:1023-33
   PubMed Web of Science ®Google Scholar
• Yamaura K, Oda M, Suwa E, Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J Toxicol Sci 2009;34:427-31
   PubMed Web of Science ®Google Scholar
• Gschwandtner M, Mommert S, Kother B, The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Invest Dermatol 2011;131:1668-76
   PubMed Web of Science ®Google Scholar
• Yu B, Shao Y, Li P, Copy number variations of the human histamine H4 receptor gene are associated with systemic lupus erythematosus. Br J Dermatol 2010;163:935-40
   PubMedGoogle Scholar
• Mommert S, Gschwandtner M, Gutzmer R, Werfel T. The role of the histamine H4 receptor in atopic dermatitis. Curr Allergy Asthma Rep 2011;11:21-8
   PubMed Web of Science ®Google Scholar
• Cowden JM, Riley JP, Ma JY, Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respir Res 2010;11:86
   PubMed Web of Science ®Google Scholar
• Alfon J, Ardanaz N, Gil-Torregrosa B, UR-60427, a novel H4 receptor-inverse agonist that shows good efficacy in a rat asthma model. Inflamm Res 2010;59(Suppl 2):S199-200
   Google Scholar
• Matsuda N, Teramae H, Futatsugi M, Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB. J Pharmacol Exp Ther 2010;332:730-7
   PubMedGoogle Scholar
• Takahashi Y, Kagawa Y, Izawa K, Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int Immunopharmacol 2009;9:734-8
   PubMed Web of Science ®Google Scholar
• Leonardi A, Di Stefano A, Vicari C, Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis. Allergy 2011;66:1360-6
   PubMed Web of Science ®Google Scholar
• Zampeli E, Thurmond RL, Tiligada E. The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva. Inflamm Res 2009;58:285-91
   PubMed Web of Science ®Google Scholar
• Nakano Y, Takahashi Y, Ono R, Role of histamine H(4) receptor in allergic conjunctivitis in mice. Eur J Pharmacol 2009;608:71-5
   PubMed Web of Science ®Google Scholar
• Lim HD, van Rijn RM, Ling P, Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 2005;314:1310-21
   PubMed Web of Science ®Google Scholar
• Coruzzi G, Pozzoli C, Adami M, Strain-dependent effects of the histamine H(4) receptor antagonist JNJ7777120 in a murine model of acute skin inflammation. Exp Dermatol 2012;21:32-7
   PubMedGoogle Scholar
• Janssen Pharmaceutica Nv. Use of histamine H4 antagonist for the treatment of post-operative adhesions. WO152287; 2009
   Google Scholar
• Connelly WM, Shenton FC, Lethbridge N, The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 2009;157:55-63
   PubMed Web of Science ®Google Scholar
• Lethbridge NL, Chazot PL. Immunological identification of the mouse H4 histamine receptor on spinal cord motor neurons using a novel anti-mouse H4R antibody. Inflamm Res 2010;59(Suppl 2):S197-8
   PubMedGoogle Scholar
• Mommert S, Gschwandtner M, Koether B, Human memory Th17 cells express a functional histamine H4 receptor. Am J Pathol 2011; [Epub ahead of print]
   PubMedGoogle Scholar
• Del Rio R, Noubade R, Saligrama, Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system. J Immunol 2011; [Epub ahead of print]
   Google Scholar
• Cowart MD, Altenbach RJ, Liu H, Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 2008;51:6547-57
   PubMed Web of Science ®Google Scholar
• Hsieh GC, Chandran P, Salyers AK, H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav 2010;95:41-50
   PubMed Web of Science ®Google Scholar
• INSERM. Selective histamine H4 receptor antagonists for the treatment of vestibular disorders. WO072829; 2010
   Google Scholar
• Venable JD, Cai H, Chai W, Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists. J Med Chem 2005;48:8289-98
   PubMed Web of Science ®Google Scholar
• Massari NA, Medina VA, Martinel Lamas DJ, Role of H4 receptor in histamine-mediated responses in human melanoma. Melanoma Res 2011;21:395-404
   PubMedGoogle Scholar
• Medina VA, Brenzoni PG, Lamas DJ, Role of histamine H4 receptor in breast cancer cell proliferation. Front Biosci (Elite Ed) 2011;3:1042-60
   PubMedGoogle Scholar
• Fang Z, Yao W, Xiong Y, Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression. BMC Cancer 2011;11:195:1-11
   Google Scholar
• Centre National De La Recherche Scientifique. Use of histamine H4 receptor ligands to protect haematopoietic progenitors against the haematological toxicity of chemotherapeutic agents. WO006974; 2008
   Google Scholar
• Seifert R, Schneider EH, Dove S, Paradoxical stimulatory effects of the "standard" histamine H4-receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity. Mol Pharmacol 2011;79:631-8
   PubMed Web of Science ®Google Scholar
• Schnell D, Brunskole I, Ladova K, Expression and functional properties of canine, rat, and murine histamine H4 receptors in Sf9 insect cells. Naunyn Schmiedebergs Arch Pharmacol 2011;383:457-70
   PubMedGoogle Scholar
• Rosethorne EM, Charlton SJ. Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits beta-arrestin without activating G proteins. Mol Pharmacol 2011;79:749-57
   PubMedGoogle Scholar
• World Intellectual Property Organization (WIPO). Available from: http://www.wipo.int/patentscope/search/en/structuredSearch.jsf [Last accessed 7 January 2012]
   Google Scholar
• Kottke T, Sander K, Weizel L, Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands. Eur J Pharmacol 2011;654:200-8
   PubMedGoogle Scholar
• Wittmann HJ, Elz S, Seifert R, Straber A. N(alpha)-Methylated phenylhistamines exhibit affinity to the hH(4)R – a pharmacological and molecular modelling study. Naunyn Schmiedebergs Arch Pharmacol 2011;384:287-99
   PubMedGoogle Scholar
• Wijtmans M, de Graaf C, de Kloe G, Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity. J Med Chem 2011;54:1693-703
   PubMed Web of Science ®Google Scholar
• Lim HD, Istyastono EP, van de Stolpe A, Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies. Bioorg Med Chem 2009;17:3987-94
   PubMed Web of Science ®Google Scholar
• Igel P, Schneider E, Schnell D, N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent. J Med Chem 2009;52:2623-7
   PubMed Web of Science ®Google Scholar
• Igel P, Geyer R, Strasser A, Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists. J Med Chem 2009;52:6297-313
   PubMed Web of Science ®Google Scholar
• Geyer R, Buschauer A. Synthesis and Histamine H(3) and H(4) receptor activity of conformationally restricted cyanoguanidines related to UR-PI376. Arch Pharm (Weinheim) 2011;344:775-85
   PubMedGoogle Scholar
• Lee-Dutra A, Arienti KL, Buzard DJ, Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands. Bioorg Med Chem Lett 2006;16:6043-8
   PubMed Web of Science ®Google Scholar
• Savall BM, Edwards JP, Venable JD, Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands. Bioorg Med Chem Lett 2010;20:3367-71
   PubMedGoogle Scholar
• Schneider EH, Strasser A, Thurmond RL, Seifert R. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands. J Pharmacol Exp Ther 2010;334:513-21
   PubMed Web of Science ®Google Scholar
• Janssen Pharmaceutica Nv. Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor. WO079001; 2009
   Google Scholar
• Mowbray CE, Bell AS, Clarke NP, Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist. Bioorg Med Chem Lett 2011;21:6596-602
   PubMed Web of Science ®Google Scholar
• Pfizer Ltd. Combination for treating inflammatory diseases. WO089748; 2005
   Google Scholar
• Deml KF, Beermann S, Neumann D, Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor. Mol Pharmacol 2009;76:1019-30
   PubMedGoogle Scholar
• Wagner E, Wittmann HJ, Elz S, Strasser A. Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R. Bioorg Med Chem Lett 2011;21:6274-80
   PubMedGoogle Scholar
• Kalypsys, Inc., Alcon Research Ltd. Heterocyclic inhibitors of histamine receptors for the treatment of disease. WO030785; 2010
   Google Scholar
• Kalypsys, Inc. Heterocyclic inhibitors of histamine receptors for the treatment of disease. WO112731; 2011
   Google Scholar
• Smits RA, Adami M, Istyastono EP, Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists. J Med Chem 2010;53:2390-400
   PubMed Web of Science ®Google Scholar
• Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patientenzorg. Quinazolines and related heterocyclic compounds, and their therapeutic use. WO083608; 2009
   Google Scholar
• Smits RA, Lim HD, van der Meer T, Ligand based design of novel histamine H(4) receptor antagonists; fragment optimization and analysis of binding kinetics. Bioorg Med Chem Lett 2011; [Epub ahead of print]
   Google Scholar
• Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patientenzorg. Quinazoline derivatives as histamine H4-receptor inhibitors for use in the treatment of inflammatory disorders. WO146173; 2010
   Google Scholar
• Verheij MH, de Graaf C, de Kloe GE, Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A. Bioorg Med Chem Lett 2011;21:5460-4
   PubMed Web of Science ®Google Scholar
• Sander K, Kottke T, Proschak E, Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands. Inflamm Res 2010;59(Suppl 2):S249-51
   Google Scholar
• Masood MA, Selby MD, Bell AS, Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR). Bioorg Med Chem Lett 2011;21:6591-5
   PubMedGoogle Scholar
• Shin N, Covington M, Bian D, INCB38579, a novel and potent histamine H(4) receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions. Eur J Pharmacol 2011; [Epub ahead of print]
   Google Scholar
• Incyte Corp. Substituted pyrimidine derivatives as antagonists of the histamine H4 receptor. WO108059; 2010
   Google Scholar
• Incyte Corp. 4,6-disubstituted 2-amino-pyrimidines as histamine H4 receptor modulators. WO075270; 2010
   Google Scholar
• Meduna SP, Savall BM, Cai H, Triamino pyrimidines and pyridines as histamine H(4) receptor modulators. Bioorg Med Chem Lett 2011;21:3113-16
   PubMedGoogle Scholar
• Palau Pharma, S. A. 2-amino-pyrimidine derivatives as histamine H4 antagonists. WO068512; 2009
   Google Scholar
• Palau Pharma, S. A. 2-aminopyrimidine derivatives as histamine H4 antagonists. WO077608; 2009
   Google Scholar
• Palau Pharma, S. A. 4-amino-pyrimidine derivatives. WO080721; 2009
   Google Scholar
• Palau Pharma, S. A. Piperidin-pyrimidine derivatives as antagonists of histamine H4 receptor. WO094721; 2010
   Google Scholar
• Palau Pharma, S. A. Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists. WO076878; 2011
   Google Scholar
• Janssen Pharmaceutica Nv. Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor. WO152325; 2009
   Google Scholar
• Janssen Pharmaceutica Nv. Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor. WO035671; 2009
   Google Scholar
• UCB Pharma, SA. Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof. WO122378; 2008
   Google Scholar
• Cramp S, Dyke HJ, Higgs C, Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists. Bioorg Med Chem Lett 2010;20:2516-19
   PubMedGoogle Scholar
• Cellzome UK Ltd. Pyrimidine compounds for the treatment of inflammatory disorders. WO039467; 2007
   Google Scholar
• Cellzome UK Ltd. Sulphur containing amino pyrimidine compounds for the treatment of inflammatory disorders. EP2020412; 2009
   Google Scholar
• Koenig JR, Liu H, Drizin I, Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring. Bioorg Med Chem Lett 2010;20:1900-4
   PubMedGoogle Scholar
• Abbott Laboratories. Tricyclic spiro pyrimidine derivatives as histamine H4 ligand. WO114575; 2009
   Google Scholar
• Abbott Laboratories. 5,6,7,8-tetrahydroquinazolin-2-amine derivatives and related compounds as histamine H4 receptor modulators for the treatment of asthma. WO123967; 2009
   Google Scholar
• Strakhova MI, Cuff CA, Manelli AM, In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties. Br J Pharmacol 2009;157:44-54
   PubMed Web of Science ®Google Scholar
• Abbott Laboratories. Heteroaryl-fused macrocyclic pyrimidine derivatives. WO137492; 2009
   Google Scholar
• Abbott Laboratories. Substituted pyrimidine derivatives as histamine H4 receptor ligands. WO134726; 2009
   Google Scholar
• Savall BM, Gomez L, Chavez F, Tricyclic aminopyrimidine histamine H4 receptor antagonists. Bioorg Med Chem Lett 2011;21:6577-81
   PubMedGoogle Scholar
• Janssen Pharmaceutica Nv. Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor. WO038673; 2009
   Google Scholar
• Palau Pharma, SA. Furo[3,2-d]pyrimidine derivatives. WO056551; 2009
   Google Scholar
• Furo[3,2-d]pyrimidine derivatives as H4 receptor antagonists. WO115496; 2009
   Google Scholar
• Palau Pharma, SA. 2H-Pyrazolo[4,3-d]pyrimidin-5-amine derivatives as H4 histamine receptor antagonists for the treatment of allergic, immunological and inflammatory diseases. WO043633; 2010
   Google Scholar
• Dainippon Sumitomo Pharma Co., Ltd. Novel bicyclic pyrimidine derivative having antagonistic activity on H4 receptor. WO107767; 2009
   Google Scholar
• Dainippon Sumitomo Pharma Co., Ltd. Novel 7-substituted dihydropyranopyrimidine derivative having H4 receptor antagonistic activity. WO064705; 2010
   Google Scholar
• Shionogi & Co., Ltd. Pyrimidine derivatives and pharmaceutical composition containing same. WO078143; 2011
   Google Scholar
• Kalypsys, Inc, Alcon Research, Ltd. Aminopyrimidine inhibitors of histamine receptors for the treatment of disease. WO030757; 2010
   Google Scholar
• Kalypsys, Inc. Heterocyclic inhibitors of histamine receptors for the treatment of disease. WO112687; 2011
   Google Scholar
• Lim HD, Smits RA, Bakker RA, Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. J Med Chem 2006;49:6650-1
   PubMed Web of Science ®Google Scholar
• Lim HD, Adami M, Guaita E, Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430. Br J Pharmacol 2009;157:34-43
   PubMed Web of Science ®Google Scholar
• Kalypsys Inc. Heterocyclic inhibitors of histamine receptors for the treatment of disease. WO112766; 2011
   Google Scholar
• Walter M, Kottke T, Stark H. The histamine H4 receptor: targeting inflammatory disorders. Eur J Pharmacol 2011;668:1-5
   PubMed Web of Science ®Google Scholar
• Available from: http://www.palaupharma.com/media/uploads/pipeline/10/Factsheet%20UR-63325%20Summer%202010.pdf [Last accessed 14 January 2012]
   Google Scholar
• Available from: http://clinicaltrials.gov/ct2/show/NCT01260753?term=UR-63325&rank=1,2010 [Last accessed 14 January 2012]
   Google Scholar
• Available from: http://www.palaupharma.com/media/uploads/pipeline/6/Factsheet%20UR-65318%20Autumn%202011.pdf [Last accessed 14 January 2012]
   Google Scholar